Crepeault H, Ti L, Jutras-Aswad D, Wood E, Le Foll B, Lim R, Bach P, Brar R, Socías ME Correlates of nonfatal overdose among treatment-seeking individuals with non-heroin opioid use disorder: findings from a pragmatic, pan-Canadian, randomized control trial J Subst Use Addict Treat PubMed

Socías ME, Choi JC, Fairbairn N, Johnson C, Wilson D, DeBeck K, Brar R, Hayashi K Impacts of the COVID-19 pandemic on enrollment in medications for opioid use disorder (MOUD) in Vancouver, Canada: an interrupted time series analysis Int J Drug Policy PubMed

Giang K, Charlesworth R, Thulien M, Mulholland A, Barker B, Brar R, Pauly B, Fast D Risk mitigation guidance and safer supply prescribing among young people who use drugs in the context of COVID-19 and overdose emergencies Int J Drug Policy PubMed

Moallef S, DeBeck K, Fairbairn N, Cui Z, Brar R, Wilson D, Johnson C, Milloy MJ, Hayashi K Inability to contact opioid agonist therapy prescribers during the COVID-19 pandemic in a Canadian setting: a cross-sectional analysis among people on opioid agonist therapy Addict Sci Clin Pract PubMed

MacKinnon L, Choi JC, Kennedy MC, Brar R, Milloy MJ, Hayashi K, Socías ME Medical detoxification for nonopioid substances is associated with lower likelihood of subsequent linkage to substance use disorder treatment J Addict Med PubMed

MacKinnon L, Kerman N, Socías ME, Brar R, Bardwell G Primary care embedded within permanent supportive housing for people who use substances: a qualitative study examining healthcare access in Vancouver, Canada Health Soc Care Community PubMed

Hong R, Brar R, Fairbairn N Supporting self-isolation for COVID-19 with "risk mitigation" prescribing and housing supports for people who use drugs: a case report J Addict Med PubMed

Glegg S, McCrae K, Kolla G, Touesnard N, Turnbull J, Brothers T, Brar R, Sutherland C, Le Foll B, Sereda A, Goyer M, Rai N, Bernstein S, Fairbairn N "COVID just kind of opened a can of whoop-ass": The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm reduction services in Canada Int J Drug Policy PubMed

McCrae K, Glegg S, Goyer M, Le Foll B, Brar R, Sutherland C, Fairbairn N The changing landscape of pharmaceutical alternatives to the unregulated drug supply during COVID-19 Harm Reduct J PubMed

Moshkforoush M, DeBeck K, Brar R, Fairbairn N, Cui Z, Milloy MJ, Buxton J, Oldenburger T, McLellan W, Kendall P, Sedgemore K, Wilson D, Kerr T, Hayashi K Low awareness of risk mitigation prescribing in response to dual crises of COVID-19 and overdose deaths among people who use unregulated drugs in Vancouver, Canada Harm Reduct J PubMed